Skip to search formSkip to main contentSkip to account menu

AF-219

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Introduction: MK-7264 (formerly AF-219) is a P2X3 receptor antagonist that has been shown to reduce cough frequency in patients… 
2016
2016
Introduction and objectives Effective therapies for chronic cough are a significant unmet need. Recently a P2X3 antagonist (AF… 
2016
2016
Objective: Arterial hypertension is associated with increases in both peripheral chemoreceptor reflex sensitivity and sympathetic… 
2016
2016
trolled by existing therapies owing, in part, to resistance to antihypertensive medications, poor compliance and side effects… 
2016
2016
OBJECTIVE Arterial hypertension is associated with increases in both peripheral chemoreceptor reflex sensitivity and sympathetic… 
Review
2015
Review
2015
  • D. SpinaC. Page
  • 2015
  • Corpus ID: 206974564
2015
2015
Patienten und Methoden: Die doppelblinde, placebokontrollierte Crossover-Studie wurde in einem britischen Zentrum durchgeführt… 
2014
2014
Introduction: Patients with chronic cough suffer significantly from impaired quality of life. However, safe and well-tolerated… 
2013
2013
The P2X3 antagonist AF‐219, being studied in bladder disorders, is eliminated by renal clearance. Local renal delivery of AF‐219…